一Stent DesignThe biodegradable coating (PLGA polymer combined with sirolimus crystals) was realized based on supercritical fluid technology, which gave birth to the Mistent® coronary drug-eluting stent. It has two distinctive features: "Quick Healing" and "Long-lasting Drug Efficacy". The biodegrad

Balloon catheters have revolutionized the field of interventional medicine by providing minimally invasive solutions for a variety of vascular and non-vascular conditions. These devices play a critical role in procedures ranging from angioplasty to the deployment of stents, enabling physicians to tr

We had a fantastic time at PAIRS 2025, held from April 9–12 at the Dubai World Trade Centre!

On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel's indep

On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary M

The MiStent coronary drug-eluting stent, an important overseas transformation project of Corecell Medical, has officially entered the Chinese market with two major advantages of "rapid healing and long-lasting efficacy", providing a new clinical option for PCI surgeries.This issue will introduce the

The Cathvenus® Circular Mapping Catheter, independently developed by Kossel Medtech’s subsidiary HAIYU Medical, has been approved for market release by the National Medical Products Administration (NMPA).

Mistent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medical, has officially launched in the Chinese market with two advantages of "fast healing and long efficacy", providing a new clinical choice for PCI surgery.This article brings you the design st

Author: Zhejiang Pulmonary Embolism and Deep Vein Thrombosis Prevention and Treatment AllianceBackground and ObjectivesThe Expert Consensus on the Prevention and Treatment Management Guidelines for Pulmonary Embolism and Deep Vein Thrombosis in Zhejiang Provincial Hospitals is based on the construct

At the beginning of 2025, good news keeps coming. The two products, Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Balloon Dilatation Catheter independently developed by Kossel, were approved for listing in Pakistan at the end of 2024 and then approved for listing by the Central Dr

In the rapidly evolving field of interventional cardiology, the PTCA Y connector has emerged as a pivotal component in enhancing procedural efficiency and patient safety. This device plays a crucial role during percutaneous transluminal coronary angioplasty (PTCA) procedures, facilitating seamless e

In the realm of cardiovascular interventions, understanding the tools at our disposal is paramount for achieving optimal patient outcomes. Among these tools, stents and balloon catheters are indispensable in treating a variety of vascular conditions. Their roles, while sometimes overlapping, are dis

Inflation devices are essential tools in modern medical procedures, particularly in interventional cardiology and radiology. They play a critical role in procedures involving balloon angioplasty, where precise pressure control is paramount. Understanding how to effectively use an inflation device is

In 1964, Dotter successfully treated a patient with severe femoral artery embolism using a homemade balloon catheter. Inspired by this, Gruentzig in Germany began researching the application of balloon technology to coronary arteries in 1974, and in 1977, he performed the first successful percutaneo

MiStent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medical, has officially landed in the Chinese market with two advantages of "fast healing and long efficacy", providing a new clinical choice for PCI surgery.Fast healing: Thin-wall stent + degrada

The Yelloach® Neuro Balloon Dilatation Catheter, independently developed by Kossel Medtech, has been approved for market release by the National Medical Products Administration (NMPA).

The umbrella-shaped vena cava filter VS The spindle-shaped vena cava filterThe main treatment of venous thromboembolism (VTE) is anticoagulation. In recent years, various methods such as embolectomy, Catheterdirectedthrombolysis(CDT) and percutaneousmechanical thrombectomy (PMT) have emerged one aft